<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">HET</journal-id>
<journal-id journal-id-type="hwp">sphet</journal-id>
<journal-id journal-id-type="nlm-ta">Hum Exp Toxicol</journal-id>
<journal-title>Human &amp; Experimental Toxicology</journal-title>
<issn pub-type="ppub">0960-3271</issn>
<issn pub-type="epub">1477-0903</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0960327111429137</article-id>
<article-id pub-id-type="publisher-id">10.1177_0960327111429137</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Citosol (thiamylal sodium) triggers apoptosis and affects gene expressions of murine leukemia RAW 264.7 cells</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>RS-C</given-names>
</name>
<xref ref-type="aff" rid="aff1-0960327111429137">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yu</surname>
<given-names>C-S</given-names>
</name>
<xref ref-type="aff" rid="aff2-0960327111429137">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>K-C</given-names>
</name>
<xref ref-type="aff" rid="aff3-0960327111429137">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huang</surname>
<given-names>H-Y</given-names>
</name>
<xref ref-type="aff" rid="aff4-0960327111429137">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ip</surname>
<given-names>S-W</given-names>
</name>
<xref ref-type="aff" rid="aff4-0960327111429137">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lin</surname>
<given-names>J-P</given-names>
</name>
<xref ref-type="aff" rid="aff5-0960327111429137">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chueh</surname>
<given-names>F-S</given-names>
</name>
<xref ref-type="aff" rid="aff6-0960327111429137">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>J-S</given-names>
</name>
<xref ref-type="aff" rid="aff7-0960327111429137">7</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Chung</surname>
<given-names>J-G</given-names>
</name>
<xref ref-type="aff" rid="aff8-0960327111429137">8</xref>
<xref ref-type="aff" rid="aff9-0960327111429137">9</xref>
<xref ref-type="corresp" rid="corresp1-0960327111429137"/>
</contrib>
</contrib-group>
<aff id="aff1-0960327111429137">
<label>1</label>Department of Anesthesiology, China Medical University Hospital, Taichung, Taiwan</aff>
<aff id="aff2-0960327111429137">
<label>2</label>School of Pharmacy, China Medical University, Taichung, Taiwan</aff>
<aff id="aff3-0960327111429137">
<label>3</label>Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung, Taiwan</aff>
<aff id="aff4-0960327111429137">
<label>4</label>Department of Nutrition, China Medical University, Taichung, Taiwan</aff>
<aff id="aff5-0960327111429137">
<label>5</label>School of Chinese Medicine, China Medical University, Taichung, Taiwan</aff>
<aff id="aff6-0960327111429137">
<label>6</label>Department of Health and Nutrition Biotechnology, Asia University, Taichung, Taiwan</aff>
<aff id="aff7-0960327111429137">
<label>7</label>Department of Pharmacology, China Medical University, Taichung, Taiwan</aff>
<aff id="aff8-0960327111429137">
<label>8</label>Department of Biological Science and Technology, China Medical University, Taichung, Taiwan</aff>
<aff id="aff9-0960327111429137">
<label>9</label>Department of Biotechnology, Asia University, Taichung, Taiwan</aff>
<author-notes>
<corresp id="corresp1-0960327111429137">Jing-Gung Chung, Department of Biological Science and Technology, China Medical University, No 91, Hsueh-Shih Road, Taichung 40402, Taiwan Email: <email>jgchung@mail.cmu.edu.tw</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>8</month>
<year>2012</year>
</pub-date>
<volume>31</volume>
<issue>8</issue>
<fpage>771</fpage>
<lpage>779</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Citosol (thiamylal sodium) is one of generally used anesthetic–sedative agents for clinical patients, and it has not been reported to show induction of cytotoxic effects in cancer cells, especially in mice leukemia RAW 264.7 cells in vitro. In the present study, we investigated the cytotoxic effects of citosol on mice leukemic RAW 264.7 cells, including the effects on protein and gene expression levels which are determined by Western blotting and DNA microarray methods, respectively. Results indicated that citosol induced cell morphological changes, cytotoxic effect, and induction of apoptosis in RAW 264.7 cells. Western blotting analysis demonstrated that citosol promoted the levels of Fas, cytochrome <italic>c</italic>, caspase 9 and 3 active form and Bax levels, but it suppressed Bcl-xl protein level that may lead to apoptotic death in RAW 264.7 cells. Furthermore, DNA microarray assay indicated that citosol significantly promoted the expression of 5 genes (Gm4884, Gm10883, Lce1c, Lrg1, and LOC100045878) and significantly inhibited the expression of 24 genes (Gm10679, Zfp617, LOC621831, Gm5929, Snord116, Gm3994, LOC380994, Gm5592, LOC380994, LOC280487, Gm4638, Tex24, A530064D06Rik, BC094916, EG668725, Gm189, Hist2h3c2, Gm8020, Snord115, Gm3079, Olfr198, Tdh, Snord115, and Olfr1249). Based on these observations, citosol induced cell apoptosis and influenced gene expression in mice leukemia RAW 264.7 cells in vitro.</p>
</abstract>
<kwd-group>
<kwd>citosol</kwd>
<kwd>apoptosis</kwd>
<kwd>cytochrome <italic>c</italic></kwd>
<kwd>caspase 3</kwd>
<kwd>cDNA microarray</kwd>
<kwd>RAW 264.7 cells</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0960327111429137">
<title>Introduction</title>
<p>Cancer is the major cause of death in human populations worldwide and leukemia is one of the lethal cancers.<sup>
<xref ref-type="bibr" rid="bibr1-0960327111429137">1</xref>,<xref ref-type="bibr" rid="bibr2-0960327111429137">2</xref>
</sup> In Taiwan, about 4 of 100,000 people die of leukemia each year. Based on the reports in 2009 from the Department of Health, R.O.C. (Taiwan), leukemia is the 11th most common malignancy in Taiwan.<sup>
<xref ref-type="bibr" rid="bibr3-0960327111429137">3</xref>
</sup> Current therapies for leukemia include intensive chemotherapy and/or hematopoietic stem cell transplantation.<sup>
<xref ref-type="bibr" rid="bibr4-0960327111429137">4</xref>,<xref ref-type="bibr" rid="bibr5-0960327111429137">5</xref>
</sup> In addition, imatinib for chronic myelogenous leukemia and all-trans retinoid acid for acute promyelocytic leukemia, both of which have markedly improved the prognosis by inhibiting the activities of key molecules critical for leukemogenesis.<sup>
<xref ref-type="bibr" rid="bibr6-0960327111429137">6</xref>,<xref ref-type="bibr" rid="bibr7-0960327111429137">7</xref>
</sup> However, these treatments for leukemia are still unsatisfactory due to low cure rate and occurrence of numerous side effects.</p>
<p>Recently, numerous studies have demonstrated that some fusion proteins or key transcription factors play important roles in leukemogenesis.<sup>
<xref ref-type="bibr" rid="bibr8-0960327111429137">8</xref><xref ref-type="bibr" rid="bibr9-0960327111429137"/>–<xref ref-type="bibr" rid="bibr10-0960327111429137">10</xref>
</sup> A large number of studies have focused on trying new agents or novel targets for leukemic patients.<sup>
<xref ref-type="bibr" rid="bibr11-0960327111429137">11</xref>,<xref ref-type="bibr" rid="bibr12-0960327111429137">12</xref>
</sup> Citosol (thiamylal sodium) has been used as an intravenous hypnotic drug for anesthesia.<sup>
<xref ref-type="bibr" rid="bibr13-0960327111429137">13</xref><xref ref-type="bibr" rid="bibr14-0960327111429137"/><xref ref-type="bibr" rid="bibr15-0960327111429137"/>–<xref ref-type="bibr" rid="bibr16-0960327111429137">16</xref>
</sup> However, no information regarding the effects of citosol on the cytotoxic effects, apoptosis and gene expressions associated with apoptosis in mice leukemia cells is available. Therefore, in the present study, we investigated the effects of citosol on the mice leukemia RAW 264.7 cells in vitro by examining the cytotoxic effects by measuring the gene expressions and associated proteins involved in the process of apoptosis and cell viability.</p>
</sec>
<sec id="section2-0960327111429137" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="section3-0960327111429137">
<title>Materials, chemicals, and reagents</title>
<p>Thiamylal sodium (citosol) was purchased from Shinlin Sinseng Pharmaceutical Co. Ltd (Taoyuan, Taiwan). Stock solution of citosol was dissolved in phosphate-buffered saline (PBS), and an equal volume of PBS (1%) was added to the well as controls. RNaseA, propidium iodide (PI), and 4,6-diamidino-2-phenylindole (DAPI) were purchased from Sigma-Aldrich Corp. (St Louis, MO, USA). RPMI 1640 medium, fetal calf serum (FBS), penicillin and streptomycin antibiotic mixture were purchased from Invitrogen Life Technologies (Grand Island, NY, USA). These primary antibodies against Fas, cytochrome <italic>c</italic>, apoptosis-inducing factor (AIF), endonuclease G (Endo G), caspase 9 and 3, Bax and Bcl-2, and secondary antibodies were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA).</p>
</sec>
<sec id="section4-0960327111429137">
<title>Cell culture</title>
<p>The RAW 264.7 mouse leukemia cell line was obtained from the Food Industry Research and Development Institute (Hsinchu, Taiwan). The RAW 264.7 cells were incubated in 5% CO<sub>2</sub> and at 37°C in RPMI 1640 medium with 2 mM <sc>l</sc>-glutamine, supplemented with 10% heat-inactivated FBS and 1% antibiotic/antimycotic (100 Units/ml penicillin and 100 μg/ml streptomycin).<sup>
<xref ref-type="bibr" rid="bibr17-0960327111429137">17</xref>
</sup>
</p>
</sec>
<sec id="section5-0960327111429137">
<title>Determination of morphology and percentage of viable cells</title>
<p>To examine the cell morphological changes, the cells from each treatment were examined and photographed under a phase-contrast microscope at ×200 magnification as described elsewhere.<sup>
<xref ref-type="bibr" rid="bibr18-0960327111429137">18</xref>,<xref ref-type="bibr" rid="bibr19-0960327111429137">19</xref>
</sup> The quantitative analysis of cell viability was performed by flow cytometric assay (Becton-Dickinson FACSCalibur, Franklin Lakes, NJ, USA) as previously described.<sup>
<xref ref-type="bibr" rid="bibr19-0960327111429137">19</xref>,<xref ref-type="bibr" rid="bibr20-0960327111429137">20</xref>
</sup> RAW 264.7 cells at a density of 2 × 10<sup>5</sup> cells/ml were cultured in 12-well plates and treated with 0, 0.375, 0.75, 1.5, 3, and 6 μg/ml of citosol followed by incubation for 24 h. At the end of incubation, cells were harvested from each treatment and stained with PI (4 μg/ml). Percentage of viable cells was measured by flow cytometry.</p>
</sec>
<sec id="section6-0960327111429137">
<title>DAPI nuclear staining for chromatin condensation in apoptosis</title>
<p>RAW 264.7 cells at a density of 2 × 10<sup>5</sup> cells/well were seeded in 12-well plates, were exposed to 3 μg/ml of citosol and fixed in 4% paraformaldehyde solution (Sigma-Aldrich Corp.) for 15 min followed by staining with DAPI (300 nmol/L; DAPI, Invitrogen) for 30 min at 25°C. Then the nuclear morphology or apoptotic body were visualized, examined, and photographed by fluorescence microscopy. Apoptotic cells were recognized by the condensed, fragmented, degraded nuclei and apoptotic body.<sup>
<xref ref-type="bibr" rid="bibr21-0960327111429137">21</xref>,<xref ref-type="bibr" rid="bibr22-0960327111429137">22</xref>
</sup>
</p>
</sec>
<sec id="section7-0960327111429137">
<title>Western blotting assay for examining the changes in apoptosis-associated protein levels</title>
<p>RAW 264.7 cells were placed into 6-well plates at a density of 5 × 10<sup>5</sup> cells/ml in RPMI 1640 medium with 10% FBS for 24 h. Cells in each well were treated without and with 3 μg/ml of citosol for 48 and 72 h. Cells were collected and total protein from each treatment was extracted into a high-salt buffer (PRO-PREP<sup>TM</sup> protein extraction solution, iNtRON Biotechnology, Seongnam, Gyeonggi-Do, Korea) and centrifuged at 12,000 rpm for 10 min at 4°C. The quantitated total protein from each treatment was determined by Bradford assay (Bio-Rad protein assay kit; Bio-Ray Laboratories, Richmond, CA, USA).<sup>
<xref ref-type="bibr" rid="bibr23-0960327111429137">23</xref>,<xref ref-type="bibr" rid="bibr24-0960327111429137">24</xref>
</sup> Proteins from each treatment were resolved on an SDS-polyacrylamide gel via electrophoresis (SDS-PAGE) and transferred to nitrocellulose membranes (GE Healthcare, Piscataway, NJ, USA). The membranes were incubated with a blocking buffer of 5% nonfat dry milk in Tris-buffered saline (TBS) containing TBS-Tween-20 (TBS-T) for 1 h at room temperature and then incubated with the specific primary antibodies (anti-Fas, -cytochrome <italic>c</italic>, -AIF, -Endo G, -caspase 9 and -caspase 3, -Bax, and -Bcl-2). The membranes were washed, treated with appropriate horseradish peroxidase–conjugated secondary antibodies and visualized by a chemiluminescence detection kit (GE Healthcare, Princeton, NJ, USA).<sup>
<xref ref-type="bibr" rid="bibr18-0960327111429137">18</xref>,<xref ref-type="bibr" rid="bibr24-0960327111429137">24</xref>
</sup>
</p>
</sec>
<sec id="section8-0960327111429137">
<title>cDNA microarray assay for gene expression of RAW 264.7 cells after exposure to citosol</title>
<p>RAW 264.7 cells (5 × 10<sup>5</sup> cells/ml) were seeded in 6-well plates containing RPMI 1640 medium with 10% FBS for 24 h. Cells in each well were treated for 48 h with or without3 μg/ml of citosol. Then the cells from each treatment were harvested and the total RNA was extracted using Qiagen RNeasy Mini Kit (Qiagen, Inc, Valencia, CA, USA).<sup>
<xref ref-type="bibr" rid="bibr24-0960327111429137">24</xref>,<xref ref-type="bibr" rid="bibr25-0960327111429137">25</xref>
</sup> The isolated total RNA were used for cDNA synthesis and labeling, microarray hybridization, and followed by flour-labeled cDNA hybridized their complements on the chip (Affymetrix GeneChip Human Gene 1.0 ST array, Affymetrix, Santa Clara, CA, USA). Finally the resulting localized concentrations of fluorescent molecules were detected and quantitated (Asia BioInnovations Corporation). The resulting data were analyzed by Expression Console software (Affymetrix) with default RMA parameters. Genes regulated by citosol were determined with a twofold change.<sup>
<xref ref-type="bibr" rid="bibr26-0960327111429137">26</xref>
</sup>
</p>
</sec>
<sec id="section9-0960327111429137">
<title>Statistical analysis</title>
<p>Significance of mean values between citosol-treated group and control group was obtained using Student’s <italic>t </italic>test. Data were expressed as mean ± SD. The <italic>p</italic> value &lt;0.05 was considered significant.</p>
</sec>
</sec>
<sec id="section10-0960327111429137">
<title>Results</title>
<sec id="section11-0960327111429137">
<title>Citosol induced cell morphological changes and decreased the percentage of RAW 264.7 viable cells</title>
<p>Morphological changes of RAW 264.7 cells after treatment with citosol were examined and investigated. The untreated cells (control) were maintained in original good shape. The incubation for 24 h at 3 μg/ml of citosol revealed condensation both in cytoplasm and nucleus and also apoptotic body appeared in the majority of cells (<xref ref-type="fig" rid="fig1-0960327111429137">Figure 1</xref>). Citosol treatment led to cellular morphological changes and more cells floated on the well compared to the control. Results from flow cytometric assay are shown in <xref ref-type="fig" rid="fig2-0960327111429137">Figure 2</xref>, and indicated that citosol decreased the percentage of viability and citosol at a concentration of 3–6 μg/ml led to a decrease of 55% and 81%, respectively. Also, the effective concentration for half-maximal response (EC<sub>50</sub>) values at 48 h exposure for citosol is 2.74 μg/ml using a PI exclusion method and flow cytometry. Hence, the dose of 3 μg/ml of citosol is close to EC<sub>50</sub> and used for further examinations.</p>
<fig id="fig1-0960327111429137" position="float">
<label>Figure 1.</label>
<caption>
<p>Citosol affected the cell morphology of RAW 264.7 cells. Cells cultured for 48 h with or without 3 μg/ml of citosol were examined for cell morphological changes and were photographed by a phase-contrast microscope as described in the section on Materials and methods. Scale bar, 20 μm.</p>
</caption>
<graphic xlink:href="10.1177_0960327111429137-fig1.tif"/>
</fig>
<fig id="fig2-0960327111429137" position="float">
<label>Figure 2.</label>
<caption>
<p>Citosol decreased the percentage of viability on RAW 264.7 cells. Cells were incubated with various concentrations (0, 0.375, 0.75, 1.5, 3 and 6 μg/ml) of citosol for 48 h and examined for cell viability by a propidium iodide (PI) exclusion method. The total viable cells were counted by PI incorporation and flow cytometric analysis, as described in the section on Materials and methods. Each point is mean ± SD of three experiments. ***<italic>p</italic> &lt; 0.001.</p>
</caption>
<graphic xlink:href="10.1177_0960327111429137-fig2.tif"/>
</fig>
</sec>
<sec id="section12-0960327111429137">
<title>Citosol induced apoptotic bodies and DNA damage in RAW 264.7 cells</title>
<p>Citosol-induced cell morphological changes and the reduction in the total viable cells in RAW 264.7 cells were further investigated using fluorescence photomicrographs. RAW 264.7 cells were stained with DAPI after exposure to 3 μg/ml citosol for 48 h. The results are shown in <xref ref-type="fig" rid="fig3-0960327111429137">Figure 3</xref>, which indicated that control cells were round with homogeneous nuclei, whereas citosol-treated cells showed apoptotic body (arrows; <xref ref-type="fig" rid="fig3-0960327111429137">Figure 3</xref>).</p>
<fig id="fig3-0960327111429137" position="float">
<label>Figure 3.</label>
<caption>
<p>Citosol induced chromatin condensation and DNA fragmentation in RAW 264.7 cells. Cells were treated with 3 μg/ml concentration of citosol for 48 h, and chromatin condensation and DNA fragmentation (a characteristic of apoptosis) were examined by 4,6-diamidino-2-phenylindole (DAPI) staining then cells were photographed by fluorescence microscopy as described in the section on Materials and methods. Arrows indicated damaged cells with apoptotic cells. Scale bar, 10 μm.</p>
</caption>
<graphic xlink:href="10.1177_0960327111429137-fig3.tif"/>
</fig>
</sec>
<sec id="section13-0960327111429137">
<title>Citosol changed the levels of proteins associated with apoptosis in RAW 264.7 cells</title>
<p>To examine whether citosol-induced apoptosis is related to the response of apoptosis-associated proteins, we investigated the effects of citosol on the levels of proteins associated with apoptosis in RAW 264.7 cells and the results were shown in <xref ref-type="fig" rid="fig4-0960327111429137">Figure 4</xref>. The results indicated that citosol increased the protein levels of Fas/CD95, cytochrome <italic>c</italic>, AIF, Endo G, active form of caspase 9 and 3 and Bax, but it decreased the level of Bcl-xl in RAW 264.7 cells. Hence, we suggest that cytosol-triggered apoptotic death of RAW 264.7 cells is carried out through mitochondria- and caspase cascade-dependent signaling.</p>
<fig id="fig4-0960327111429137" position="float">
<label>Figure 4.</label>
<caption>
<p>Citosol affected the levels of apoptosis-associated proteins of RAW 264.7 cells. Cells were treated with citosol at 3 μg/ml concentration for 48 and 72 h and then harvested for total protein determinations. The associated protein expressions (Fas, cytochrome <italic>c</italic>, AIF, Endo G, caspase 9 and 3, Bax, and Bcl-xl) were estimated by Western blotting as described in the section on Materials and methods. The protein level of β-actin was blotted as a protein-loading control.</p>
</caption>
<graphic xlink:href="10.1177_0960327111429137-fig4.tif"/>
</fig>
</sec>
<sec id="section14-0960327111429137">
<title>cDNA microarray analysis for citosol-induced gene expression in RAW 264.7 cells</title>
<p>The microarray analysis showed that citosol increased 5 genes which were upregulated including Gm4884, Gm10883, Lce1c, Lrg1, and LOC100045878 and it inhibited 24 genes which were downregulated including Gm10679, Zfp617, LOC621831, Gm5929, Snord116, Gm3994, LOC380994, Gm5592, LOC380994, LOC280487, Gm4638, Tex24, A530064D06Rik, BC094916, EG668725, Gm189, Hist2h3c2, Gm8020, Snord115, Gm3079, Olfr198, Tdh, Snord115, and Olfr1249 in RAW 264.7 cells that were expressed at least by a twofold change when compared with the untreated control cells (<xref ref-type="table" rid="table1-0960327111429137">Table 1</xref>). Moreover, the gene and mRNA descriptions, respectively, can be seen in <xref ref-type="table" rid="table1-0960327111429137">Table 1</xref>. Overall, the results from cDNA microarray were classified based on the top scored by the number of pathways network from GeneGo analysis program which are shown in <xref ref-type="fig" rid="fig5-0960327111429137">Figure 5</xref>. Thick cyan lines indicate the fragments of canonical pathways. These genes may also be involved in cell cycle arrest and apoptosis which are induced by citosol on RAW 264.7 cells.</p>
<fig id="fig5-0960327111429137" position="float">
<label>Figure 5.</label>
<caption>
<p>The representative possible canonical pathways from RAW 264.7 cells after exposure to citosol. Cells were exposed to 3 μg/ml of citosol, were harvested and total RNA were extracted for cDNA microarray assay. Thick cyan lines indicate the fragments of canonical pathways. Upregulated genes are marked with red circles; downregulated with blue circles. The ‘checkerboard’ color indicates mixed expression for the gene between files or between multiple tags for the same gene (AKAP28: A-kinase anchor protein, 28 kD; CNGA1: cyclic nucleotide–gated channel alpha 1; CNGA2: cyclic nucleotide–gated channel alpha 2; CNGA3: cyclic nucleotide–gated channel alpha 3; CNGA4: cyclic nucleotide–gated channel alpha 4; KCNH2: potassium voltage–gated channel, subfamily H (eag-related), member 2; SDHL: <sc>l</sc>-serine ammonia-lyase; SLC4A4: solute carrier family 4, sodium bicarbonate cotransporter, member 4; PDE4D: phosphodiesterase 4D, cAMP-specific; PDE2A: phosphodiesterase 2A, cGMP-stimulated; PRKAR2A: protein kinase, cAMP-dependent, regulatory, type II, alpha; TPH1: tryptophan hydroxylase 1).</p>
</caption>
<graphic xlink:href="10.1177_0960327111429137-fig5.tif"/>
</fig>
<table-wrap id="table1-0960327111429137" position="float">
<label>Table 1.</label>
<caption>
<p>List of genes with at least twofold changes in mRNA levels in RAW 246.7 cells after exposure to citosol identified by cDNA microarray and scored b from GeneGo analysis</p>
</caption>
<graphic alternate-form-of="table1-0960327111429137" xlink:href="10.1177_0960327111429137-table1.tif"/>
<table>
<thead>
<tr>
<th>Fold change</th>
<th>Gene symbol</th>
<th>Gene description</th>
<th>mRNA description</th>
</tr>
</thead>
<tbody>
<tr>
<td>2.526</td>
<td>Gm4884</td>
<td>Predicted gene 4884 </td>
<td>
<italic>Mus musculus </italic>predicted gene 4884 (Gm4884), mRNA</td>
</tr>
<tr>
<td>2.435 </td>
<td>Gm10883</td>
<td align="center">–</td>
<td>ENSMUSG00000076577 protein gene: ENSMUSG00000076577 </td>
</tr>
<tr>
<td>2.387 </td>
<td>Lce1c</td>
<td>Late cornified envelope 1C</td>
<td>
<italic>Mus musculus </italic>late cornified envelope 1C (Lce1c), mRNA</td>
</tr>
<tr>
<td>2.186 </td>
<td>Lrg1</td>
<td>Leucine-rich alpha-2-glycoprotein 1</td>
<td>
<italic>Mus musculus</italic> leucine-rich alpha-2-glycoprotein 1 (Lrg1), mRNA</td>
</tr>
<tr>
<td>2.014 </td>
<td>LOC100045878</td>
<td>Similar to TRAV6D-4</td>
<td>Similar to TRAV6D-4 gene: ENSMUSG00000076768</td>
</tr>
<tr>
<td>−2.008 </td>
<td>Gm10679</td>
<td>Oocyte specific homeobox 4 pseudogene </td>
<td>Similar to OBOX4 gene: ENSMUSG00000074371 </td>
</tr>
<tr>
<td>−2.011 </td>
<td>Zfp617</td>
<td>Zinc finger protein 617</td>
<td>
<italic>Mus musculus </italic>zinc finger protein 617 (Zfp617), mRNA</td>
</tr>
<tr>
<td>−2.023</td>
<td>LOC621831</td>
<td>Similar to Sycp3 like Y-linked</td>
<td>Predicted: <italic>Mus musculus </italic>similar to Sycp3 like Y-linked (LOC621831), misc RNA</td>
</tr>
<tr>
<td>−2.029 </td>
<td>Gm5929</td>
<td>Predicted gene 5929</td>
<td>Predicted: <italic>Mus musculus</italic> predicted gene, EG546249 (EG546249), misc RNA</td>
</tr>
<tr>
<td>−2.066 </td>
<td>Snord116</td>
<td>Small nucleolar RNA, C/D box 116 cluster</td>
<td>
<italic>Mus musculus</italic> Pwcr1 mRNA, complete sequence</td>
</tr>
<tr>
<td>−2.083 </td>
<td>Gm3994</td>
<td>Oocyte specific homeobox 4 pseudogene</td>
<td>Similar to OBOX4 gene:ENSMUSG00000074370 </td>
</tr>
<tr>
<td>−2.089 </td>
<td>LOC380994</td>
<td>Similar to Sycp3 like Y-linked </td>
<td>
<italic>Mus musculus</italic> similar to Sycp3 like Y-linked, mRNA, complete cds</td>
</tr>
<tr>
<td>−2.154 </td>
<td>Gm5592</td>
<td>predicted gene 5592</td>
<td>
<italic>Mus musculus</italic> predicted gene 5592 (Gm5592), mRNA</td>
</tr>
<tr>
<td>−2.162 </td>
<td>LOC380994</td>
<td>Similar to Sycp3 like Y-linked</td>
<td>
<italic>Mus musculus </italic>similar to Sycp3 like Y-linked, mRNA, complete cds</td>
</tr>
<tr>
<td>−2.233 </td>
<td>LOC280487</td>
<td align="center">–</td>
<td>Mouse RNA for type IIB intracisternal A-particle (IAP) element encoding integrase, clone 106</td>
</tr>
<tr>
<td>−2.233 </td>
<td>Gm4638</td>
<td>Predicted gene 4638</td>
<td>Predicted: <italic>Mus musculus</italic> hypothetical protein LOC100043775 (LOC100043775), mRNA</td>
</tr>
<tr>
<td>−2.270 </td>
<td>Tex24</td>
<td>Testis expressed gene 24</td>
<td>
<italic>Mus musculus </italic>testis expressed gene 24 (Tex24), mRNA</td>
</tr>
<tr>
<td>−2.368 </td>
<td>A530064D06Rik</td>
<td>RIKEN cDNA A530064D06 gene </td>
<td>
<italic>Mus musculus </italic>RIKEN cDNA A530064D06 gene (A530064D06Rik), transcript variant 1, mRNA</td>
</tr>
<tr>
<td>−2.372 </td>
<td>BC094916</td>
<td>cDNA sequence BC094916 </td>
<td>
<italic>Mus musculus</italic> cDNA sequence BC094916 (BC094916), mRNA</td>
</tr>
<tr>
<td>−2.418 </td>
<td>EG668725</td>
<td>MAS-related GPR, member A9 </td>
<td>
<italic>Mus musculus </italic>G-protein coupled adenine receptor mRNA, complete cds</td>
</tr>
<tr>
<td>−2.468 </td>
<td>Gm189</td>
<td>Predicted gene 189 </td>
<td>Anti-VIPase light chain variable region gene: ENSMUSG00000076556 </td>
</tr>
<tr>
<td>−2.499 </td>
<td>Hist2h3c2</td>
<td>Histone cluster 2, H3c2 </td>
<td>
<italic>Mus musculus</italic> histone cluster 2, H3c2 (Hist2h3c2), mRNA</td>
</tr>
<tr>
<td>−2.552 </td>
<td>Gm8020</td>
<td>Predicted gene 8020 </td>
<td>Similar to CDNA sequence BC061237 gene: ENSMUSG00000072744 </td>
</tr>
<tr>
<td>−2.588 </td>
<td>Snord115</td>
<td>Small nucleolar RNA, C/D Box 115 cluster </td>
<td>
<italic>Mus musculus</italic> clone MBII-52 C/D box snoRNA, partial sequence</td>
</tr>
<tr>
<td>−2.657 </td>
<td>Gm3079</td>
<td>Predicted gene 3079 </td>
<td>Predicted: <italic>Mus musculus</italic> hypothetical protein LOC100040985 (LOC100040985), mRNA</td>
</tr>
<tr>
<td>−2.688 </td>
<td>Olfr198</td>
<td>Olfactory receptor 198</td>
<td>
<italic>Mus musculus</italic> olfactory receptor 198 (Olfr198), mRNA</td>
</tr>
<tr>
<td>−2.827 </td>
<td>Tdh</td>
<td>
<sc>l</sc>-Threonine dehydrogenase </td>
<td>
<italic>Mus musculus</italic> l-threonine dehydrogenase (Tdh), mRNA</td>
</tr>
<tr>
<td>−2.898 </td>
<td>Snord115</td>
<td>Small nucleolar RNA, C/D Box 115 cluster </td>
<td>
<italic>Mus musculus </italic>clone MBII-52 C/D box snoRNA, partial sequence</td>
</tr>
<tr>
<td>−2.984 </td>
<td>Olfr1249</td>
<td>Olfactory receptor 1249</td>
<td>
<italic>Mus musculus</italic> olfactory receptor 1249 (Olfr1249), mRNA</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
</sec>
<sec id="section15-0960327111429137">
<title>Discussion</title>
<p>Currently, citosol is one of the most common drugs for anesthesia in clinical use.<sup>
<xref ref-type="bibr" rid="bibr16-0960327111429137">16</xref>,<xref ref-type="bibr" rid="bibr27-0960327111429137">27</xref>
</sup> There is no information to show that citosol induced cytotoxic effects in mice cells. Moreover, there is no available information addressing whether citosol affects cellular processes related to cancer. However, there are no reports on the effects of citosol on apoptosis and associated gene expressions in mice leukemia cells. Herein, the present study is the first to show that citosol can induce cytotoxic effect including induction of apoptosis and the associated gene expression changes in mice leukemia cells.</p>
<p>In this study, our results demonstrated that citosol induced cell morphological changes, decreased the percentage of total viable cells, induced apoptotic bodies as well as changed the apoptosis-associate protein levels, and gene expressions in mice leukemia RAW 264.7 cells in vitro. The EC<sub>50</sub> of citosol for cytotoxic effects is 2.74 μg/ml of cytosol for 48-h exposure (<xref ref-type="fig" rid="fig1-0960327111429137">Figure 1</xref>). This is the first study to show that citosol at a concentration of 3–6 μg/ml can decrease the percentage of viable RAW 264.7 cells.</p>
<p>Much evidence revealed that agent- or chemical compound-induced cell death would have two characteristics: necrosis and apoptosis.<sup>
<xref ref-type="bibr" rid="bibr28-0960327111429137">28</xref>,<xref ref-type="bibr" rid="bibr29-0960327111429137">29</xref>
</sup> Furthermore, the character of apoptosis included chromatin condensation and DNA damage (DNA fragmentation), apoptotic body formation, and so on.<sup>
<xref ref-type="bibr" rid="bibr30-0960327111429137">30</xref>,<xref ref-type="bibr" rid="bibr31-0960327111429137">31</xref>
</sup> Thus, we used DAPI staining to show whether citosol could induce chromatin condensation and DNA damage, and the result showed that citosol triggered apoptosis in RAW 264.7 cells (<xref ref-type="fig" rid="fig3-0960327111429137">Figure 3</xref>).</p>
<p>It is well known that the two apoptotic pathways are extrinsic and intrinsic pathways.<sup>
<xref ref-type="bibr" rid="bibr32-0960327111429137">32</xref>,<xref ref-type="bibr" rid="bibr33-0960327111429137">33</xref>
</sup> The extrinsic pathway involved the agent that induced Fas/CD95 and Fas-associated protein with death domain, which led to the activation of caspase 8 and 3, causing cell apoptosis. The intrinsic pathway involved the increase in Bax (a pro-apoptotic protein) and the decrease in Bcl-2 (an antiapoptotic protein) that cause mitochondrial dysfunction (decrease the levels of mitochondrial membrane potential) with consequent release of cytochrome <italic>c</italic> release and activation of caspase 9 and 3, causing cell apoptosis.<sup>
<xref ref-type="bibr" rid="bibr32-0960327111429137">32</xref>,<xref ref-type="bibr" rid="bibr33-0960327111429137">33</xref>
</sup> Therefore, we used Western blotting to examine whether citosol would affect apoptotic protein levels, and the results indicated that citosol promoted the levels of AIF and Endo G, and it also stimulated the level of cytochrome <italic>c </italic>in RAW 264.7 cells (<xref ref-type="fig" rid="fig4-0960327111429137">Figure 4</xref>). These observations indicated that citosol induced apoptosis through a mitochondria-dependent pathway. <xref ref-type="fig" rid="fig4-0960327111429137">Figure 4</xref> also showed that citosol promoted the level of Bax and decreased the level of Bcl-xl, which implied that citosol decreased the level of mitochondrial membrane potential (ΔΨ<italic>m</italic>). In the present study, our results showed that citosol decreased the level of Bcl-xl and promoted the level of Bax in RAW 264.7 cells, which affected the ratio of Bax/Bcl-2, leading to AIF and Endo G release from mitochondria. It was reported that some inducer of apoptosis could induce apoptosis through mitochondria and led to AIF and Endo G release, causing apoptosis.<sup>
<xref ref-type="bibr" rid="bibr34-0960327111429137">34</xref>
</sup> It was also reported that the inducer of apoptosis decreased the ratio of Bax and Bcl-xl and led to mitochondrial dysfunction thereby releasing AIF and Endo G, causing apoptosis.<sup>
<xref ref-type="bibr" rid="bibr35-0960327111429137">35</xref>,<xref ref-type="bibr" rid="bibr36-0960327111429137">36</xref>
</sup>
</p>
<p>To confirm the cytotoxic effects of citosol on apoptotic proteins involved in the associated gene expression in RAW 264.7 cells, we used cDNA microarray to examine the gene expression from RAW 264.7 cells after exposure to citosol, and our results showed that citosol significantly promoted the expression of 5 genes, including Gm4884, Gm10883, Lce1c, Lrg1, and LOC100045878, but it significantly inhibited the expression of 24 genes, including Gm10679, Zfp617, LOC621831, Gm5929, Snord116, Gm3994, LOC380994, Gm5592, LOC380994, LOC280487, Gm4638, Tex24, A530064D06Rik, BC094916, EG668725, Gm189, Hist2h3c2, Gm8020, Snord115, Gm3079, Olfr198, Tdh, Snord115, and Olfr1249 in RAW 264.7 cells as can be seen in <xref ref-type="fig" rid="fig5-0960327111429137">Figure 5</xref> and <xref ref-type="table" rid="table1-0960327111429137">Table 1</xref>.</p>
<p>In conclusion, based on these observations, citosol induced cytotoxic effects and the protein levels and gene expressions in mice leukemia RAW 264.7 cells in vitro, and our study is the first to show the cytotoxic and gene regulatory effects of citosol on mice leukemia RAW 246.7 cells.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure" id="fn1-0960327111429137">
<label>Funding</label>
<p>This work was supported by the grant DOH100-TD-C-111-005 from Taiwan Department of Health, China Medical University Hospital Cancer Research Center of Excellence.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0960327111429137">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anand</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kunnumakkara</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Sundaram</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Cancer is a preventable disease that requires major lifestyle changes</article-title>. <source>Pharm Res</source> <year>2008</year>; <volume>25</volume>: <fpage>2097</fpage>–<lpage>2116</lpage>.</citation>
</ref>
<ref id="bibr2-0960327111429137">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wiemels</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Cazzaniga</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Daniotti</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Prenatal origin of acute lymphoblastic leukaemia in children</article-title>. <source>Lancet</source> <year>1999</year>; <volume>354</volume>: <fpage>1499</fpage>–<lpage>1503</lpage>.</citation>
</ref>
<ref id="bibr3-0960327111429137">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Kuo</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>MH</given-names>
</name>
<etal/>
</person-group>. <article-title>Extract of Hedyotis diffusa willd influences murine leukemia WEHI-3 cells in vivo as well as promoting T- and B-cell proliferation in leukemic mice</article-title>. <source>In Vivo</source> <year>2011</year>; <volume>25</volume>: <fpage>633</fpage>–<lpage>640</lpage>.</citation>
</ref>
<ref id="bibr4-0960327111429137">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nau</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>WD</given-names>
</name>
</person-group>. <article-title>Multiple myeloma: diagnosis and treatment</article-title>. <source>Am Fam Physician</source> <year>2008</year>; <volume>78</volume>: <fpage>853</fpage>–<lpage>859</lpage>.</citation>
</ref>
<ref id="bibr5-0960327111429137">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fotoohi</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Assaraf</surname>
<given-names>YG</given-names>
</name>
<name>
<surname>Moshfegh</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Gene expression profiling of leukemia T-cells resistant to methotrexate and 7-hydroxymethotrexate reveals alterations that preserve intracellular levels of folate and nucleotide biosynthesis</article-title>. <source>Biochem Pharmacol</source> <year>2009</year>; <volume>77</volume>: <fpage>1410</fpage>–<lpage>1417</lpage>.</citation>
</ref>
<ref id="bibr6-0960327111429137">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoshimi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kurokawa</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Key roles of histone methyltransferase and demethylase in leukemogenesis</article-title>. <source>J Cell Biochem</source> <year>2011</year>; <volume>112</volume>: <fpage>415</fpage>–<lpage>424</lpage>.</citation>
</ref>
<ref id="bibr7-0960327111429137">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Kuo</surname>
<given-names>CL</given-names>
</name>
<etal/>
</person-group>. <article-title>Solanum lyratum extract affected immune response in normal and leukemia murine animal in vivo</article-title>. <source>Hum Exp Toxicol</source> <year>2010</year>; <volume>29</volume>: <fpage>359</fpage>–<lpage>367</lpage>.</citation>
</ref>
<ref id="bibr8-0960327111429137">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lorsbach</surname>
<given-names>RB</given-names>
</name>
<name>
<surname>Downing</surname>
<given-names>JR</given-names>
</name>
</person-group>. <article-title>The role of the AML1 transcription factor in leukemogenesis</article-title>. <source>Int J Hematol</source> <year>2001</year>; <volume>74</volume>: <fpage>258</fpage>–<lpage>265</lpage>.</citation>
</ref>
<ref id="bibr9-0960327111429137">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sano</surname>
<given-names>K</given-names>
</name>
</person-group>. <article-title>Structure of AF3p21, a new member of mixed lineage leukemia (MLL) fusion partner proteins-implication for MLL-induced leukemogenesis</article-title>. <source>Leuk Lymphoma</source> <year>2001</year>; <volume>42</volume>: <fpage>595</fpage>–<lpage>602</lpage>.</citation>
</ref>
<ref id="bibr10-0960327111429137">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ayton</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Cleary</surname>
<given-names>ML</given-names>
</name>
</person-group>. <article-title>Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins</article-title>. <source>Oncogene</source> <year>2001</year>; <volume>20</volume>: <fpage>5695</fpage>–<lpage>5707</lpage>.</citation>
</ref>
<ref id="bibr11-0960327111429137">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gratacap</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Valera</surname>
<given-names>MC</given-names>
</name>
<etal/>
</person-group>. <article-title>The new tyrosine-kinase inhibitor and anticancer drug dasatinib reversibly affects platelet activation in vitro and in vivo</article-title>. <source>Blood</source> <year>2009</year>; <volume>114</volume>: <fpage>1884</fpage>–<lpage>1892</lpage>.</citation>
</ref>
<ref id="bibr12-0960327111429137">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matsunaga</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Fukai</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Miura</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Combination therapy of an anticancer drug with the FNIII14 peptide of fibronectin effectively overcomes cell adhesion-mediated drug resistance of acute myelogenous leukemia</article-title>. <source>Leukemia</source> <year>2008</year>; <volume>22</volume>: <fpage>353</fpage>–<lpage>360</lpage>.</citation>
</ref>
<ref id="bibr13-0960327111429137">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hori</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hiraga</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>The effects of thiamylal sodium on the tonic vibration reflex in man</article-title>. <source>Brain Res</source> <year>1989</year>; <volume>497</volume>: <fpage>291</fpage>–<lpage>295</lpage>.</citation>
</ref>
<ref id="bibr14-0960327111429137">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shimoji</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kano</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nakashima</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>The effects of thiamylal sodium on electrical activities of the central and peripheral nervous systems in man</article-title>. <source>Anesthesiology</source> <year>1974</year>; <volume>40</volume>: <fpage>234</fpage>–<lpage>240</lpage>.</citation>
</ref>
<ref id="bibr15-0960327111429137">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gaynor</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Bednarski</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Muir</surname>
<given-names>WW</given-names>
<suffix>III</suffix>
</name>
</person-group>. <article-title>Effect of hypercapnia on the arrhythmogenic dose of epinephrine in horses anesthetized with guaifenesin, thiamylal sodium, and halothane</article-title>. <source>Am J Vet Res</source> <year>1993</year>; <volume>54</volume>: <fpage>315</fpage>–<lpage>321</lpage>.</citation>
</ref>
<ref id="bibr16-0960327111429137">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mokriski</surname>
<given-names>BK</given-names>
</name>
<name>
<surname>Nagle</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Papuchis</surname>
<given-names>GC</given-names>
</name>
<etal/>
</person-group>. <article-title>Electroconvulsive therapy-induced cardiac arrhythmias during anesthesia with methohexital, thiamylal, or thiopental sodium</article-title>. <source>J Clin Anesth</source> <year>1992</year>; <volume>4</volume>: <fpage>208</fpage>–<lpage>212</lpage>.</citation>
</ref>
<ref id="bibr17-0960327111429137">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chiou</surname>
<given-names>WF</given-names>
</name>
<name>
<surname>Don</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>JF</given-names>
</name>
<etal/>
</person-group>. <article-title>Psoralidin inhibits LPS-induced iNOS expression via repressing Syk-mediated activation of PI3K-IKK-IkappaB signaling pathways</article-title>. <source>Eur J Pharmacol</source> <year>2011</year>; <volume>650</volume>: <fpage>102</fpage>–<lpage>109</lpage>.</citation>
</ref>
<ref id="bibr18-0960327111429137">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>FS</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>CS</given-names>
</name>
<etal/>
</person-group>. <article-title>Safrole induces apoptosis in human oral cancer HSC-3 cells</article-title>. <source>J Dent Res</source> <year>2011</year>; <volume>90</volume>: <fpage>168</fpage>–<lpage>174</lpage>.</citation>
</ref>
<ref id="bibr19-0960327111429137">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>PP</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>WW</given-names>
</name>
<etal/>
</person-group>. <article-title>Triptolide induces apoptosis in human adrenal cancer NCI-H295 cells through a mitochondrial-dependent pathway</article-title>. <source>Oncol Rep</source> <year>2011</year>; <volume>25</volume>: <fpage>551</fpage>–<lpage>557</lpage>.</citation>
</ref>
<ref id="bibr20-0960327111429137">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Hang</surname>
<given-names>LW</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>JS</given-names>
</name>
<etal/>
</person-group>. <article-title>Curcumin induces apoptosis in human non-small cell lung cancer NCI-H460 cells through ER stress and caspase cascade- and mitochondria-dependent pathways</article-title>. <source>Anticancer Res</source> <year>2010</year>; <volume>30</volume>: <fpage>2125</fpage>–<lpage>2133</lpage>.</citation>
</ref>
<ref id="bibr21-0960327111429137">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>AC</given-names>
</name>
<etal/>
</person-group>. <article-title>Chrysophanol induces necrosis through the production of ROS and alteration of ATP levels in J5 human liver cancer cells</article-title>. <source>Mol Nutr Food Res</source> <year>2010</year>; <volume>54</volume>: <fpage>967</fpage>–<lpage>976</lpage>.</citation>
</ref>
<ref id="bibr22-0960327111429137">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>HF</given-names>
</name>
<name>
<surname>Chie</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>MS</given-names>
</name>
<etal/>
</person-group>. <article-title>Apigenin induces apoptosis in human lung cancer H460 cells through caspase- and mitochondria-dependent pathways</article-title>. <source>Hum Exp Toxicol</source> <year>2010</year>; <volume>30</volume>: <fpage>1053</fpage>–<lpage>1061</lpage>.</citation>
</ref>
<ref id="bibr23-0960327111429137">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>HY</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>HF</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>JS</given-names>
</name>
<etal/>
</person-group>. <article-title>The novel quinolone CHM-1 induces DNA damage and inhibits DNA repair gene expressions in a human osterogenic sarcoma cell line</article-title>. <source>Anticancer Res</source> <year>2010</year>; <volume>30</volume>: <fpage>4187</fpage>–<lpage>4192</lpage>.</citation>
</ref>
<ref id="bibr24-0960327111429137">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chiang</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>CY</given-names>
</name>
<etal/>
</person-group>. <article-title>Danthron, an anthraquinone derivative, induces DNA damage and caspase cascades-mediated apoptosis in SNU-1 human gastric cancer cells through mitochondrial permeability transition pores and Bax-triggered pathways</article-title>. <source>Chem Res Toxicol</source> <year>2011</year>; <volume>24</volume>: <fpage>20</fpage>–<lpage>29</lpage>.</citation>
</ref>
<ref id="bibr25-0960327111429137">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>JS</given-names>
</name>
<etal/>
</person-group>. <article-title>Danthron inhibits the migration and invasion of human brain glioblastoma multiforme cells through the inhibition of mRNA expression of focal adhesion kinase, Rho</article-title> <article-title>kinases-1 and metalloproteinase-9</article-title>. <source>Oncol Rep</source> <year>2009</year>; <volume>22</volume>: <fpage>1033</fpage>–<lpage>1037</lpage>.</citation>
</ref>
<ref id="bibr26-0960327111429137">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jacobs</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Marnett</surname>
<given-names>LJ</given-names>
</name>
</person-group>. <article-title>HSF1-mediated BAG3 expression attenuates apoptosis in 4-hydroxynonenal-treated colon cancer cells via stabilization of anti-apoptotic Bcl-2 proteins</article-title>. <source>J Biol Chem</source> <year>2009</year>; <volume>284</volume>: <fpage>9176</fpage>–<lpage>9183</lpage>.</citation>
</ref>
<ref id="bibr27-0960327111429137">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orallo</surname>
<given-names>MO</given-names>
</name>
<name>
<surname>Eather</surname>
<given-names>KF.</given-names>
</name>
</person-group> <article-title>Sodium methohexital as a rectal agent in pediatric anesthesia: a controlled comparison with sodium thiamylal</article-title>. <source>Anesth Analg</source> <year>1965</year>; <volume>44</volume>: <fpage>97</fpage>–<lpage>103</lpage>.</citation>
</ref>
<ref id="bibr28-0960327111429137">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Madge</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Sierra-Honigmann</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Pober</surname>
<given-names>JS</given-names>
</name>
</person-group>. <article-title>Apoptosis-inducing agents cause rapid shedding of tumor necrosis factor receptor 1 (TNFR1). A nonpharmacological explanation for inhibition of TNF-mediated activation</article-title>. <source>J Biol Chem</source> <year>1999</year>; <volume>274</volume>: <fpage>13643</fpage>–<lpage>13649</lpage>.</citation>
</ref>
<ref id="bibr29-0960327111429137">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jori</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Fabris</surname>
<given-names>C</given-names>
</name>
</person-group>. <article-title>Relative contributions of apoptosis and random necrosis in tumour response to photodynamic therapy: effect of the chemical structure of Zn(II)-phthalocyanines</article-title>. <source>J Photochem Photobiol B</source> <year>1998</year>; <volume>43</volume>: <fpage>181</fpage>–<lpage>185</lpage>.</citation>
</ref>
<ref id="bibr30-0960327111429137">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Mattson</surname>
<given-names>MP</given-names>
</name>
</person-group>. <article-title>Caspase-mediated suppression of glutamate (AMPA) receptor channel activity in hippocampal neurons in response to DNA damage promotes apoptosis and prevents necrosis: implications for neurological side effects of cancer therapy and neurodegenerative disorders</article-title>. <source>Neurobiol Dis</source> <year>2001</year>; <volume>8</volume>: <fpage>194</fpage>–<lpage>206</lpage>.</citation>
</ref>
<ref id="bibr31-0960327111429137">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fenech</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Crott</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Necrosis, apoptosis, cytostasis and DNA damage in human lymphocytes measured simultaneously within the cytokinesis-block micronucleus assay: description of the method and results for hydrogen peroxide</article-title>. <source>Mutagenesis</source> <year>1999</year>; <volume>14</volume>: <fpage>605</fpage>–<lpage>612</lpage>.</citation>
</ref>
<ref id="bibr32-0960327111429137">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsuchiya</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Asada</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Arita</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Induction and mechanism of apoptotic cell death by propofol in HL-60 cells</article-title>. <source>Acta Anaesthesiol Scand</source> <year>2002</year>; <volume>46</volume>: <fpage>1068</fpage>–<lpage>1074</lpage>.</citation>
</ref>
<ref id="bibr33-0960327111429137">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chien</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>YC</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>JG</given-names>
</name>
<etal/>
</person-group>. <article-title>Quercetin-induced apoptosis acts through mitochondrial- and caspase-3-dependent pathways in human breast cancer MDA-MB-231 cells</article-title>. <source>Hum Exp Toxicol</source> <year>2009</year>; <volume>28</volume>: <fpage>493</fpage>–<lpage>503</lpage>.</citation>
</ref>
<ref id="bibr34-0960327111429137">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>YT</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>PP</given-names>
</name>
<etal/>
</person-group>. <article-title>The roles of AIF and Endo G in the apoptotic effects of benzyl isothiocyanate on DU 145 human prostate cancer cells via the mitochondrial signaling pathway</article-title>. <source>Int J Oncol</source> <year>2011</year>; <volume>38</volume>: <fpage>787</fpage>–<lpage>796</lpage>.</citation>
</ref>
<ref id="bibr35-0960327111429137">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tait</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>DR</given-names>
</name>
</person-group>. <article-title>Mitochondria and cell death: outer membrane permeabilization and beyond</article-title>. <source>Nat Rev Mol Cell Biol</source> <year>2010</year>; <volume>11</volume>: <fpage>621</fpage>–<lpage>632</lpage>.</citation>
</ref>
<ref id="bibr36-0960327111429137">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>HF</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Chuang</surname>
<given-names>YY</given-names>
</name>
<etal/>
</person-group>. <article-title>Danthron induced apoptosis through mitochondria- and caspase-3-dependent pathways in human brain glioblastoma multiforms GBM 8401 cells</article-title>. <source>Neurochem Res</source> <year>2010</year>; <volume>35</volume>: <fpage>390</fpage>–<lpage>398</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>